We are
Our Purpose
We believe that meaningful progress in medicine requires models that respect biological complexity, reduce unnecessary reliance on animal testing, and generate knowledge that is relevant to human health.
Our Mission
Our mission is to accelerate therapies for neuromuscular and neurodegenerative diseases by providing predictive, scalable, and ethical human-based in vitro models that replace animal testing.
Our Vision
Our vision is to make human-relevant testing the global standard, empowering laboratories worldwide to develop safer, more effective therapies faster and with greater confidence in human outcomes.
The Science Behind Our Platforms
Accelerate breakthroughs with human-based organ-on-a-chip solutions for neuroscience that deliver faster, more predictive results.
The Challenge
Current Animal Preclinical Models are not Sufficient
Drug discovery and neurotoxicity testing still lack scalable, functional human models that truly reflect how neurons and muscles behave in the body.
Neuronal networks are complex, highly interconnected systems.
Conventional 2D cultures lack reproducible functional organization.
Animal models often fail to accurately predict human responses.
The Need
Human-relevant Data that Scales with Development
Meaningful translation requires models that replicate how human neurons and muscles interact - structurally, functionally, and over time.
Microenvironment and architecture shape neuronal and neuromuscular behavior.
Three-dimensional organization enables functional connectivity.
Human-based systems enhance translational relevance.
Real-time, multiparametric data supports informed development decisions.
20
Independent NMJs per plate
28
independent Test units per NHTS
Our Solutions
Human-Relevant Platforms
Ananda delivers human-relevant organ-on-a-chip platforms that recreate functional neuronal and neuromuscular biology — enabling translational, scalable research across discovery stages.
NeuroMuscle™ recreates functional human neuromuscular junctions in 3D for mechanistic and efficacy studies.
NeuroHTS™ enables high-throughput, reproducible neuronal network screening at scale.
*
Integrated, multiparametric readouts support informed decision-making across development
Our Milestones
2015
2019
2021
2023
2024
2025
2026
Ananda Devices founded
Established to translate organ-on-a-chip research into scalable, human-relevant platforms for drug discovery and toxicity testing.
NeuroHTS™ commercial launch
Introduced standardized, high-throughput human neuronal networks, supporting partners through expert CRO services.
Translational Impact with UCB Pharma
NeuroMuscle™ supported the development of two neuromuscular therapies, including zilucoplan® for myasthenia gravis, by modeling complement-driven NMJ dysfunction in human systems.
FDA partnership announced
Began regulatory qualification of NeuroMuscle™ as a Drug Development Tool, presented at the MPS World Summit in Berlin.
Regulatory validation milestones achieved
Joint studies with the U.S. FDA confirmed robustness, reproducibility, and human predictive value for evaluation of neuromusclular toxins.
PARTNERSHIP
Collaboration with FUJIFILM Cellular Dynamics (FCDI)
Initiated co-development of Ready-to-Use NeuroMuscle™, featuring live, pre-integrated iPSC-derived cells.
NeuroMuscle™ Implemented in FDA Laboratories
Deployed for botulinum neurotoxin (BoNT) detection and neuromuscular safety programs.
Worldwide Commercial Launch of NeuroMuscle™ & NeuroHTS™ Products
Accelerating NAM adoption with easy to use products from Ananda Devices
Launched SaaS Customer Portal
Website access portal adding machine learning, multi-parametric image analysis to our product capabilities
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
Terms and Conditions
Languages: EN
We are
Our Purpose
We believe that meaningful progress in medicine requires models that respect biological complexity, reduce unnecessary reliance on animal testing, and generate knowledge that is relevant to human health.
Our Mission
Our mission is to accelerate therapies for neuromuscular and neurodegenerative diseases by providing predictive, scalable, and ethical human-based in vitro models that replace animal testing.
Our Vision
Our vision is to make human-relevant testing the global standard, empowering laboratories worldwide to develop safer, more effective therapies faster and with greater confidence in human outcomes.
The Science Behind Our Platforms
Accelerate breakthroughs with human-based organ-on-a-chip solutions for neuroscience that deliver faster, more predictive results.
The Challenge
Current Animal Preclinical Models are not Sufficient
Drug discovery and neurotoxicity testing still lack scalable, functional human models that truly reflect how neurons and muscles behave in the body.
Neuronal networks are complex, highly interconnected systems.
Conventional 2D cultures lack reproducible functional organization.
Animal models often fail to accurately predict human responses.
The Need
Human-relevant Data that Scales with Development
Meaningful translation requires models that replicate how human neurons and muscles interact - structurally, functionally, and over time.
Microenvironment and architecture shape neuronal and neuromuscular behavior.
Three-dimensional organization enables functional connectivity.
Human-based systems enhance translational relevance.
Real-time, multiparametric data supports informed development decisions.
20
Independent NMJs per plate
28
independent Test units per NHTS
Our Solutions
Human-Relevant Platforms
Ananda delivers human-relevant organ-on-a-chip platforms that recreate functional neuronal and neuromuscular biology — enabling translational, scalable research across discovery stages.
NeuroMuscle™ recreates functional human neuromuscular junctions in 3D for mechanistic and efficacy studies.
NeuroHTS™ enables high-throughput, reproducible neuronal network screening at scale.
*
Integrated, multiparametric readouts support informed decision-making across development
Our Milestones
2015
2019
2021
2023
2024
2025
2026
Ananda Devices founded
Established to translate organ-on-a-chip research into scalable, human-relevant platforms for drug discovery and toxicity testing.
NeuroHTS™ commercial launch
Introduced standardized, high-throughput human neuronal networks, supporting partners through expert CRO services.
Translational Impact with UCB Pharma
NeuroMuscle™ supported the development of two neuromuscular therapies, including zilucoplan® for myasthenia gravis, by modeling complement-driven NMJ dysfunction in human systems.
FDA partnership announced
Began regulatory qualification of NeuroMuscle™ as a Drug Development Tool, presented at the MPS World Summit in Berlin.
Regulatory validation milestones achieved
Joint studies with the U.S. FDA confirmed robustness, reproducibility, and human predictive value for evaluation of neuromusclular toxins.
PARTNERSHIP
Collaboration with FUJIFILM Cellular Dynamics (FCDI)
Initiated co-development of Ready-to-Use NeuroMuscle™, featuring live, pre-integrated iPSC-derived cells.
NeuroMuscle™ Implemented in FDA Laboratories
Deployed for botulinum neurotoxin (BoNT) detection and neuromuscular safety programs.
Worldwide Commercial Launch of NeuroMuscle™ & NeuroHTS™ Products
Accelerating NAM adoption with easy to use products from Ananda Devices
Launched SaaS Customer Portal
Website access portal adding machine learning, multi-parametric image analysis to our product capabilities
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
Terms and Conditions
Languages: EN
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN
About Us
We are
Our Purpose
We believe that meaningful progress in medicine requires models that respect biological complexity, reduce unnecessary reliance on animal testing, and generate knowledge that is relevant to human health.
Our Mission
Our mission is to accelerate therapies for neuromuscular and neurodegenerative diseases by providing predictive, scalable, and ethical human-based in vitro models that replace animal testing.
Our Vision
Our vision is to make human-relevant testing the global standard, empowering laboratories worldwide to develop safer, more effective therapies faster and with greater confidence in human outcomes.
The Science Behind Our Platforms
Accelerate breakthroughs with human-based organ-on-a-chip solutions for neuroscience that deliver faster, more predictive results.
The Challenge
Current Animal Preclinical Models are not Sufficient
Drug discovery and neurotoxicity testing still lack scalable, functional human models that truly reflect how neurons and muscles behave in the body.
Neuronal networks are complex, highly interconnected systems.
Conventional 2D cultures lack reproducible functional organization.
Animal models often fail to accurately predict human responses.
The Need
Human-relevant Data that Scales with Development
Meaningful translation requires models that replicate how human neurons and muscles interact - structurally, functionally, and over time.
Microenvironment and architecture shape neuronal and neuromuscular behavior.
Three-dimensional organization enables functional connectivity.
Human-based systems enhance translational relevance.
Real-time, multiparametric data supports informed development decisions.
20
Independent NMJs per plate
28
independent Test units per NHTS
Our Solutions
Human-Relevant Platforms
Ananda delivers human-relevant organ-on-a-chip platforms that recreate functional neuronal and neuromuscular biology — enabling translational, scalable research across discovery stages.
NeuroMuscle™ recreates functional human neuromuscular junctions in 3D for mechanistic and efficacy studies.
NeuroHTS™ enables high-throughput, reproducible neuronal network screening at scale.
*
Integrated, multiparametric readouts support informed decision-making across development
Our Milestones
2015
2019
2021
2023
2024
2025
2026
Ananda Devices founded
Established to translate organ-on-a-chip research into scalable, human-relevant platforms for drug discovery and toxicity testing.
Accelerate breakthroughs with human-based organ-on-a chip solutions that deliver faster, more predictive results.
Main Page
Home
About Us
Our Platforms
Our Services
Our News
Contact Us
Our Resources
Product literature
Publications
News&Events
Webinars
Copyright© 2026 Ananda Device. inc
|
Terms and Conditions
|
Languages: EN
Home
About Us
Our Platforms
Our Services
Our Resources
Contact Us
Client Portal
EN